Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1145460/000095014217001346/eh1700795_8k.htm
October 2017
September 2017
August 2017
July 2017
July 2017
June 2017
June 2017
May 2017
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1145460/000095014217001346/eh1700795_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alere Inc..
Alere Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Alere Inc. provided additional information to their SEC Filing as exhibits
CIK: 1145460Events:
Form Type: 8-K Corporate News
Accession Number: 0000950142-17-001346
Submitted to the SEC: Mon Jul 17 2017 5:12:07 PM EST
Accepted by the SEC: Mon Jul 17 2017
Period: Saturday, July 15, 2017
Industry: In Vitro And In Vivo Diagnostic Substances